These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24359947)

  • 1. Visualizing of signaling proteins on endosomes utilizing knockdown and reconstitution approach.
    Jeoung M; Galperin E
    Methods Enzymol; 2014; 534():47-63. PubMed ID: 24359947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endosomal targeting of MEK2 requires RAF, MEK kinase activity and clathrin-dependent endocytosis.
    Galperin E; Sorkin A
    Traffic; 2008 Sep; 9(10):1776-90. PubMed ID: 18657070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytosis separates EGF receptors from endogenous fluorescently labeled HRas and diminishes receptor signaling to MAP kinases in endosomes.
    Pinilla-Macua I; Watkins SC; Sorkin A
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2122-7. PubMed ID: 26858456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
    Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cells.
    Galperin E; Abdelmoti L; Sorkin A
    PLoS One; 2012; 7(5):e36469. PubMed ID: 22606262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial control of Shoc2-scaffold-mediated ERK1/2 signaling requires remodeling activity of the ATPase PSMC5.
    Jang ER; Jang H; Shi P; Popa G; Jeoung M; Galperin E
    J Cell Sci; 2015 Dec; 128(23):4428-41. PubMed ID: 26519477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of extracellular signal-regulated kinase 1/2 bistability and sustained activation through Sprouty 2 and its relevance for epithelial function.
    Liu W; Tundwal K; Liang Q; Goplen N; Rozario S; Quayum N; Gorska M; Wenzel S; Balzar S; Alam R
    Mol Cell Biol; 2010 Apr; 30(7):1783-99. PubMed ID: 20123980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAP kinase: it's been longer than fifteen minutes.
    Sturgill TW
    Biochem Biophys Res Commun; 2008 Jun; 371(1):1-4. PubMed ID: 18406346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
    Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of protein kinase C theta contributes to enhanced myogenesis in vitro via IRS1 and ERK1/2 phosphorylation.
    Marino JS; Hinds TD; Potter RA; Ondrus E; Onion JL; Dowling A; McLoughlin TJ; Sanchez ER; Hill JW
    BMC Cell Biol; 2013 Sep; 14():39. PubMed ID: 24053798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPIN90 knockdown attenuates the formation and movement of endosomal vesicles in the early stages of epidermal growth factor receptor endocytosis.
    Oh H; Kim H; Chung KH; Hong NH; Shin B; Park WJ; Jun Y; Rhee S; Song WK
    PLoS One; 2013; 8(12):e82610. PubMed ID: 24340049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral vectors to study the differential function of ERK1 and ERK2 MAP kinases.
    Indrigo M; Papale A; Orellana D; Brambilla R
    Methods Mol Biol; 2010; 661():205-20. PubMed ID: 20811985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated ERK1/2 MAP kinase signaling promotes aneuploidy by a Fbxw7β-Aurora A pathway.
    Duhamel S; Girondel C; Dorn JF; Tanguay PL; Voisin L; Smits R; Maddox PS; Meloche S
    Cell Cycle; 2016 Jun; 15(12):1631-42. PubMed ID: 27152455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone and protein kinase C signaling to ERK: spatiotemporal regulation of ERK by docking domains and dual-specificity phosphatases.
    Armstrong SP; Caunt CJ; McArdle CA
    Mol Endocrinol; 2009 Apr; 23(4):510-9. PubMed ID: 19179479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
    Hong SK; Wu PK; Karkhanis M; Park JI
    Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vascular endothelial growth factor with shRNA in chondrocytes ameliorates osteoarthritis.
    Zhang X; Crawford R; Xiao Y
    J Mol Med (Berl); 2016 Jul; 94(7):787-98. PubMed ID: 27164955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hCG activates Epac-Erk1/2 signaling regulating Progesterone Receptor expression and function in human endometrial stromal cells.
    Tapia-Pizarro A; Archiles S; Argandoña F; Valencia C; Zavaleta K; Cecilia Johnson M; González-Ramos R; Devoto L
    Mol Hum Reprod; 2017 Jun; 23(6):393-405. PubMed ID: 28333280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential phosphorylation of the phosphoinositide 3-phosphatase MTMR2 regulates its association with early endosomal subtypes.
    Franklin NE; Bonham CA; Xhabija B; Vacratsis PO
    J Cell Sci; 2013 Mar; 126(Pt 6):1333-44. PubMed ID: 23378027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells.
    Liang Z; Pan Q; Zhang Z; Huang C; Yan Z; Zhang Y; Li J
    Mol Med Rep; 2019 Nov; 20(5):4507-4514. PubMed ID: 31702027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.